Dec 17, 2025 05:31AM Solid Biosciences (SLDB) in Good Position with Capsid, Dystrophin - Citizens

Dec 16, 2025 04:51PM HHS adds duchenne muscular dystrophy to newborn screening panel

Dec 4, 2025 06:41AM Needham Starts Solid Biosciences (SLDB) at Buy

Dec 1, 2025 08:04AM Solid Biosciences gets FDA rare pediatric disease status for SGT-212

Nov 17, 2025 08:04AM Solid Biosciences licenses capsid technology to Andelyn Biosciences

Nov 6, 2025 08:04AM Solid Biosciences gains UK Innovation Passport for Duchenne gene therapy

Nov 3, 2025 04:46PM Solid Biosciences (SLDB) Misses Q3 EPS by 48c

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Sep 23, 2025 08:00AM Solid Biosciences licenses gene therapy capsid to Kinea Bio

Sep 22, 2025 07:16AM Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)

Sep 12, 2025 04:10AM Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

Aug 14, 2025 04:22AM Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

Aug 12, 2025 05:48PM Solid Biosciences (SLDB) Misses Q2 EPS by 42c

Jul 23, 2025 08:00AM Solid Biosciences gets FDA fast track status for CPVT gene therapy

Jul 21, 2025 07:52AM Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)

Jul 21, 2025 04:17AM Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

Jul 17, 2025 04:50AM Citi Opens Catalyst Call on Solid Biosciences (SLDB)

Jul 11, 2025 07:02AM Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)

Jul 8, 2025 04:05PM Solid Biosciences receives FDA, Health Canada approval for CPVT gene therapy

Jun 26, 2025 05:02AM Citi Starts Solid Biosciences (SLDB) at Buy

Jun 17, 2025 06:45AM Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)

Jun 17, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Solid Biosciences (SLDB)

May 16, 2025 10:52AM Truist Securities Reiterates Buy Rating on Solid Biosciences (SLDB)

May 16, 2025 09:51AM Solid Biosciences (SLDB) PT Lowered to $17 at Piper Sandler

May 16, 2025 04:13AM Solid Biosciences (SLDB) PT Lowered to $15 at Jefferies

May 16, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

May 15, 2025 06:49PM Solid Biosciences (SLDB) Misses Q1 EPS by 59c

Apr 1, 2025 07:03AM Climb Bio (CLYM) Appoints Kim Cobleigh Drapkin and Bo Cumbo to its Board

Mar 31, 2025 07:25AM Truist: 'Expect Some Pressure On Dr. Marks' Resignation'

Mar 10, 2025 06:44AM Solid Biosciences (SLDB) PT Raised to $20 at H.C. Wainwright

Mar 7, 2025 04:32AM Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

Mar 6, 2025 05:25PM Solid Biosciences (SLDB) Misses Q4 EPS by 100c

Mar 4, 2025 04:54PM Solid Biosciences (SLDB) reports inducement grants

Feb 19, 2025 04:46AM Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

Feb 18, 2025 07:01AM Solid Biosciences (SLDB) Prices 35.74M Share Offering at $4.03/sh

Feb 18, 2025 06:47AM Solid Biosciences (SLDB) Reports Positive Initial Clinical Data from SGT-003

Feb 5, 2025 05:05AM JMP Securities Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

Jan 21, 2025 08:31AM Solid Biosciences (SLDB) Receives FDA Fast Track Designation for SGT-212

Jan 15, 2025 04:06PM Solid Biosciences (SLDB) Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

Jan 8, 2025 06:05AM Truist Securities Starts Solid Biosciences (SLDB) at Buy

Jan 7, 2025 04:15PM Solid Biosciences (SLDB) Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'

Dec 23, 2024 04:06PM Solid Biosciences (SLDB) Added to the Nasdaq Biotechnology Index

Dec 10, 2024 03:19AM JMP Securities Starts Solid Biosciences (SLDB) at Market Outperform

Dec 4, 2024 08:02AM Solid Biosciences (SLDB) Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

Nov 7, 2024 04:55PM Solid Biosciences (SLDB) Misses Q3 EPS by 79c

Aug 13, 2024 04:23PM Solid Biosciences (SLDB) Reports Q1 Loss of $0.61/sh

Jul 15, 2024 03:03AM JPMorgan Upgrades Solid Biosciences (SLDB) to Overweight

Jun 13, 2024 07:59AM Piper Sandler Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)